课题基金 / 基金详情

DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS

DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
双脱氧核苷作为潜在的抗艾滋病药物
批准号:
3838034
负责人:
V E MARQUEZ
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

V E MARQUEZ的其他基金

相似基金

相关文献

中文摘要
翻译
一系列新的糖基修饰2‘,3’-二脱氧-2‘,3’-二氟核苷 并测定了它们的核磁共振溶液构象。 特定形式的环状褶皱与抗艾滋病毒活性相关。 几种新型的发酵扩环碳环类似物 合成产物oxetanocin A并对其抗HIV活性进行评价 活动。与双脱氧核糖相反,这些化合物 缺乏抗艾滋病病毒的活性。 选择酸性稳定的6-X-取代-(2‘-氟-2’, 3‘-dideoxy-beta-D-threo-pentofuranosyl)purines(X=F,Cl,Br,I,NHMe, Nhet、NHOH、NHOMe、NHOCH2 Ph)作为抗HIV腺苷 脱氨酶激活的“前药物”。他们的评估正在进行中。
英文摘要
A series of new sugar-modified 2',3'-dideoxy-2',3'-difluoro nucleosides were synthesized and the NMR solution conformations were determined. Specific forms of ring puckering were correlated with anti-HIV activity. A number of novel ring-expanded carbocyclic analogues of the fermentation product oxetanocin A were synthesized and evaluated for anti-HIV activity. As opposed to the dideoxyribose counterparts, these compounds were devoid of anti-HIV activity. Selected acid-stable 6-X-substituted-(2'-fluoro-2', 3'-dideoxy-beta-D-threo-pentofuranosyl)purines (X = F, Cl, Br, I, NHMe, NHEt, NHOH, NHOMe, NHOCH2 Ph) were prepared as anti-HIV adenosine deaminase-activated "pro-drugs". Their evaluation is in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ENZYME INHIBITORS AS PROTENTIAL ANTICANCER AND ANTIVIRAL DRUGS
  • 批准号:
    5201243
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    V E MARQUEZ
  • 依托单位:
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
  • 批准号:
    5201241
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    V E MARQUEZ
  • 依托单位:
CYCLOPENTENYL NUCLEOSIDE ISOSTERES AS POTENTIAL ANTITUMOR AND ANTIVIRAL AGENTS
  • 批准号:
    5201242
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    V E MARQUEZ
  • 依托单位:
DIDEOXYNUCLEOSIDES AS POTENTIAL ANTI-AIDS DRUGS
海外基金